NeuroSense Therapeutics Ltd.

NRSN

—

Advanced chart & tools →

NeuroSense Therapeutics Ltd.NRSN

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.44

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

—

Net income

$-11.13M

Net margin

—

Gross margin

—

Dividends & financials

NeuroSense Therapeutics Ltd. (NRSN) reported revenue of — and net income of $-11.13M, or $-0.44 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.